Pharmacokinetic drug interactions of azoles |
| |
Authors: | Roger J. M. Brüggemann Jan-Willem C. Alffenaar Nicole M. A. Blijlevens Eliane M. Billaud Jos G. W. Kosterink Paul E. Verweij David M. Burger |
| |
Affiliation: | (1) Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands |
| |
Abstract: | Drug-drug interactions are a major concern with triazoles. Azoles are potent metabolic inhibitors and interactions commonly occur via metabolizing enzymes (ie, cytochrome P450 isoenzyme superfamily) or drug transporters (ie, P-glycoprotein). However, the clinical relevance of these interactions may vary upon the azole involved and upon the “target” drug. Azoles may also be under influence of and become targets of metabolic drug-drug interactions. Potential interactions between antifungal agents and over-the-counter or alternative medicines and herbs should not be underestimated. Here, we provide a comprehensive overview of different types of pharmacokinetic drug interactions involving azoles with selected examples. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|